江剑平;胡粉娟;陈雅娟;

• 1:福建师范大学生命科学学院
• 2:福建省发育和神经生物学重点实验室

摘要(Abstract)：

观察椎管内注射感觉神经元特异性受体选择性激动剂牛肾上腺髓质8-22肽(bovine adrenal me-dulla 8-22,BAM8-22)在福尔马林引起的持续性痛中对吗啡耐受的影响.结果表明,吗啡(20μg)在正常大鼠中能显著抑制福尔马林引起的痛行为,多次应用吗啡导致耐受后,其抑制痛行为的能力大大减弱(P<0.001);吗啡耐受后,BAM8-22(0.1 nmol)能翻转吗啡的耐受效应,福尔马林引起第2期抬足/舔爪持续时间和抖动次数分别减少了39.4%(P<0.001)和25.3%(P<0.05).每天椎管内联合应用BAM8-22(0.1 nmol)和吗啡(20μg)不影响吗啡耐受的形成,但隔天给予BAM8-22则能有效延缓吗啡耐受的形成,福尔马林引起第2期缩足舔爪和抖动分别为14.7 min和234.5次,与吗啡耐受鼠相比,分别减少了41.0%(P<0.001)和24.8%(P<0.05).然而,BAM8-22并没有完全翻转或抑制吗啡的耐受(P<0.001).此外,连续6 d给予BAM8-22后会降低吗啡在福尔马林持续痛中的抗伤害作用.证明在福尔马林引起的持续性痛中,SNSR受体参与了调制阿片受体的敏感性.同时,提示在持续性痛中,通过BAM8-22延缓或翻转吗啡耐受是利用阿片受体治疗持续性痛的有效方法.

关键词(KeyWords)： 牛肾上腺髓质8-22肽(BAM8-22);吗啡耐受;持续性痛;福尔马林实验

Abstract:

Keywords:

基金项目(Foundation): 福建省教育厅资助项目(JK2010014;09037)

作者(Authors): 江剑平;胡粉娟;陈雅娟;

参考文献(References)：

• [1]Lembo P M,Grazzini E,Groblewski T,et al.Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs[J].Nat Neurosci,2002,5(3):201-209.
• [2]Dong X,Han S,Zylka M J,et al.A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neu-rons[J].Cell,2001,106(5):619-632.
• [3]Snider W D,McMahon S B.Tackling pain at the source:new ideas about nociceptors[J].Neuron,1998,20(4):629-632.
• [4]Chen T,Cai Q,Hong Y.Intrathecal sensory neuron-specifc receptor agonists bovine adrenal medulla8-22and(Tyr6)-γ2-MSH-6-12inhibit formalin-evoked nociception and neuronal Fos-like immunoreactivity in the spinal cord of the rat[J].Neuroscience,2006,141(2):965-975.
• [5]Chen T,Hu Z,Quirion R,et al.Modulation of NMDA receptors by intrathecal administration of the sensory neuron-spe-cific receptor agonist BAM8-22[J].Neuropharmacology,2008,54(5):796-803.
• [6]Jiang J,Huang J,Hong Y.Bovine adrenal medulla22reverses antinociceptive morphine tolerance in the rat[J].BehavBrain Res,2006,168(1):167-171.
• [7]江剑平,陈雅娟,洪炎国.椎管内注射牛肾上腺髓质22肽差异性翻转吗啡耐受作用[J].生理学报,2006,58(6):529-535.
• [8]Cai Q,Jiang J,Chen T,et al.Sensory neuron-specific receptor agonist BAM8-22inhibits the development and expres-sion of tolerance to morphine in rats[J].Behav Brain Res,2007,178(1):154-159.
• [9]Yaksh T L,Rudy T A.Chronic catheterization of the spinal subarachnoid space[J].Physiol Behav,1976,17(6):1031-1036.
• [10]Wheeler-Aceto H,Cowan A.Standardization of the rat paw formalin test for the evaluation of analgesics[J].Psycho-pharmacology,1991,104(1):35-44.
• [11]Hong Y,Dai P,Jiang J,et al.Dual effects of intrathecal BAM22on nociceptive responses in acute and persistent pain-potential function of a novel receptor[J].Br J Pharmacol,2004,141(4):423-430.
• [12]Hong Y,Abbott F V.Contribution of peripheral alpha1A-adrenoceptors to pain induced by formalin or by alpha-methyl-5-hydroxytryptamine plus noradrenaline[J].Eur J Pharmacol,1996,301(1/3):41-48.
• [13]江剑平,付艳,张文华,等.牛肾上腺髓质8-22肽增加吗啡抗伤害作用[J].福建师范大学学报:自然科学版,2009,25(2):97-100.
• [14]Dubuisson D,Dennis S G.The formalin test:a quantitative study of the analgesic effects of morphine,meperidine,and brain stem stimulation in rats and cats[J].Pain,1977,4(2):161-174.
• [15]Tjolsen A,Berge O G,Hunskaar S,et al.The formalin test:an evaluation of the method[J].Pain,1992,51(1):5-17.
• [16]Hunskaar S,Hole K.The formalin test in mice:dissociation between inflammatory and non-inflammatory pain[J].Pain,1987,30(1):103-114.
• [17]Wheeler-Aceto H,Porreca F,Cowan A.The rat paw formalin test:comparison of noxious agents[J].Pain,1990,40(2):229-238.
• [18]Porro C A,Cavazzuti M.Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model[J].Prog Neurobiol,1993,41(5):565-607.
• [19]Coderre T J,Vaccarino A L,Melzack R.Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection[J].Brain Res,1990,535(1):155-158.
• [20]Bailey C P,Connor M.Opioids:cellular mechanisms of tolerance and physical dependence[J].Curr Opin Pharma-col,2005,5(1):60-68.